Based on the Basic Health Research Data of Ministry of Health's of Indonesia in 2013, mortality rates from malignant and tumor malignancies in Indonesia are still high with prevalence of cancer is about 1.4%. Chemotherapy is still the primary choice in cancer modality that uses chemotherapeutic drugs to eradicate and inhibit the growth of cancer cells; however the cost this treatment is extremely high. Therefore, patient tends to seek alternative treatment such as consuming traditional herbal medicine for cancer treatment. Rutin is one of the attractive phytochemicals flavonoids because of its antioxidant activities. However, as traditional herbal medicine, its effectiveness is not yet been fully established due to the lack of scientific information. A radiotracer can be defined as a specific radiolabeled molecule that monitors the in vivo behaviour of a functional molecule, and can be used to provide biological information in a living system. Hence, to provide pharmacological information of rutin for cancer treatment, we synthesized radiolabeled flavonoid 99m Tc-rutin as radiotracer. The aim of the present study is to develop 99m Tc-rutin under varying conditions of rutin quantity, reducing agent concentration and incubation time. Labeling studies were performed by changing the selected parameters one by one and optimum labeling conditions were determined. After observing the conditions for maximum labeling efficiency, 99m Tc-rutin was obtained with preparation of 700 μg of rutin with addition of 20 μg of SnCl 2 .2H 2 O as reductor and 1-3 mCi 99m TcO4-without any incubation. Radiochemical yield of 99m Tc-rutin was determined with radio thin layer chromatography which was found 99.28 ± 0.14% and stable up to 4 hour. From the result of this study, the successfully labeled 99m Tc-rutin can be used as a reference for following preclinical study. Furthermore radiolabeled 99m Tc-rutin is expected as tools in research and development of rutin as cancer drugs from natural product to obtain detailed information its efficacy.
INTRODUCTION
Based on the Global Cancer Statistic 2012 Data, mortality rates from malignant and tumour malignancies in the world are still high (8.2 million deaths) with the prevalence of cancer is about 14.1 million case (Torre, et al., 2015) . Chemotherapy is still the primary choice in cancer modality that uses chemotherapeutic drugs to eradicate and inhibit the growth of cancer cells, however the cost this treatment is extremely high. Therefore, the patient tends to seek alternative treatment such as consuming traditional herbal medicine for cancer treatment (Institute for Health Metrics and Evaluation University of Washington, 2017) .
Flavonoids are a class of natural compounds which have abundant availability found in plants, these compounds play an important role in the treatment of various disorders because of its pharmacological properties therefore it was an excellent source of pharmaceutical products for phytotherapy. Rutin (3′,4′,5,7-tetrahydroxyflavone-3-rutinoside) (Figure 1 ) is one of the attractive phytochemicals flavonoids because of its pharmacological activities including anti-oxidation, anti-inflammation, anti-diabetic, anti-adipogenic, neuroprotective and hormone therapy (Lambrecht, et al., 2010; Sharma, et al., 2013; Chua, 2013) . Through its antioxidants activity, rutin has received considerable interest due to their potential roles in the prevention and treatment of cancer by protecting cells against the effects of free radicals. Rutin was apparently inhibiting the process of angiogenesis in cancer cells where this process may stop cancer form new blood vessels which needed by cancer cells to grow and develop (Jain, et al., 2012; Dixit, 2014) . Rutin is mostly found in edible plants such as onions, apples, berries, tea and wine (Atanassova & Bagdassarian, 2009 ). However, as traditional herbal medicine, its effectiveness is not yet been fully established due to the lack of scientific information, therefore its efficacy and safety should be evaluated scientifically.
In recent years, kind of researches had reported in vivo biological and pharmacological activities of rutin. Most of the pharmacological activities parameters of rutin have been investigated using conventional tools such as High Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). However, those methods require a complicated process, time consuming and costly. Nuclear technology provides several advantages over conventional methods in terms of detection and availability sensitivity. The labeling technique using radioisotopes on flavonoids as radiotracer has been done to determine the biodistribution and pharmacokinetic patterns in some flavonoid compounds (Hosseinimehr, et al., 2010; Jeon, et al., 2015; Seyitoglu, et al., 2009; Sriyani, et al., 2015; Xie, et al., 2017; Choi, et al., 2016) . A radiotracer can be defined as a specific radiolabeled molecule that monitors the in vivo behaviour of a functional molecule, and can be used to provide biological information in a living system. Therefore, the radiolabeled rutin as radiotracer will be useful to understanding its antioxidants activity and determine their efficacy and effectiveness as anti-cancer. Previous research on 99m Tc-rutin has been carried out by Bernardo, et al., but does not explain the optimum conditions for labeled rutin with technetium-99m radioisotopes (Djelili, et al., 2012) Indones. J. Cancer Chemoprevent., 10(2), 80-87 (Bernardo, et al., 2001 ). The present study was conducted to develop 99m Tc-rutin under varying conditions of rutin quantity, reducing agent concentration and incubation time conditions for maximum labeling efficiency. This study will give the good preparation of 99m Tc-rutin with high radiochemical yield for the development of 99m Tc-rutin as radiotracer.
MATERIAL AND METHODS
The materials that used to this research were rutin (Sigma Aldrich, Steinheim Germany), tin ( The equipment that used in this experiment were dose calibrator (Victoreen, Melbourne USA), vortex mixer, single channel analyzer (Ortec, Canberra Australia), and paper chromatography apparatus.
Labeling of
99m Tc-rutin Labeling of rutin with radioisotope technetium-99m was performed using direct labeling method using SnCl 2 .2H 2 O as reducing agent. Some parameters were varying to obtain the optimum conditions such as incubation time, amount of SnCl 2 and rutin. The labeling process was carried out by adding of SnCl 2 solution (1 mg/mL HCl 0.1 N) into the vial that contains rutin solution in ethanol, then incubated in room temperature for 10 minutes. After incubation time reached, phosphate buffer 0.2N with pH 7.5 was added into the vial. A saline solution of 99m TcO 4 -with an activity of 1-3 mCi was injected into the vial and its volume was adjusted to 1.5 mL. All experiments were carried out in a volume of 1.5 mL and incubation at room temperature.
Determination of Labeling Efficiency of 99m Tc-rutin
The determination of labeling efficiency/ radiochemical purity of o C, and then every 1 cm piece of paper was cut and measured using Single Channel Analyzer (SCA) with NaI(Tl) detector.
Optimization of Reducing Agent SnCl 2 .2H 2 O
Into five vials containing 500 µL rutin (1 mg/mL) were added varying amount (10, 20, 30, 40 , and 50 μL) of SnCl 2 (1 mg/mL) and added water to adjust the final volume to 600 mL, then incubation for 10 minutes in room temperature. After incubation time reached, 500 mL phosphate buffer 0.2 N solutions with pH 7.5 were added into the vials. Then a solution Na 99m TcO 4 with an activity of 1-3 mCi was added. The mixture was shaken with a vortex mixer until homogenous and then incubated at room temperature for 30 minutes. The optimum amount of reducing agent was determined from the labeling efficiency of 99m Tc-rutin using TLC method as described above.This test is repeated as many as three times.
Optimization of Rutin Amount
Into each vial, containing varying concentrations of rutin (500, 600, 700, 800, and 900 µg/500 µL) were added the optimum SnCl 2 amount (20 µg/20 µL) and added water to adjust the final volume to 600 mL, then incubation for 10 minutes in room temperature. After incubation time reached, 500 mL phosphate buffer 0.2 N solutions with pH 7.5 were added into the vials. Then a solution Na 99m TcO 4 with an activity of 1-3 mCi/ 400 µL was added. The mixture was shaken with a vortex mixer until homogenous and then incubated at room temperature for 30 minutes. The optimum amount of rutin was determined from the labeling efficiency of 99m Tc-rutin using TLC method. This test is repeated as many as three times.
Optimization of Incubation Time
Labeling was done by adding 20 μL of SnCl 2 solution (1 mg/mL) into a vial containing 0.7 mg of rutin that was dissolved in 500 µL of ethanol. To adjusted the final volume to 600 mL was added 80 µL of water and then the solution was incubation for 10 minutes in room temperature. After the incubation time reached, 1-3 mCi/400 µL of Na 99m TcO 4 solution was added. The mixture was stirred gently until homogeneous and incubated at room temperature for varying periods of time i.e., 0, 15, 30, 45, and 60 minutes. The optimum incubation time will be the time that gives a high labeling efficiency of 99m Tc-rutin. The labeling efficiency was determined when the intended incubation interval was reached; the labeling efficiency was determined using TLC method as described above. This test is repeated as many as three times. The labelled compounds   99m Tc-rutin that obtained from the optimum conditions are as follows: Into a vial containing 0.7 mg/500 µL of rutin solution was added 20 μL of SnCl 2 solution (1 mg/mL) as reductor and 80 µL of water. The mixture was incubation for 10 minutes in room temperature. After the incubation time reached, 1-3 mCi/400 µL of Na 99m TcO 4 solution was added. Rutin was successfully labelled using technetium-99m without any incubation time. Stability testing was performed at 0, 1, 2, 3, and 4 hours after adding Na 99m TcO 4 to see the stability of 99m Tc-rutin. Stability data was then analyzed by using bidirectional ANOVA followed by Tukey analysis with two parameters of time and radiochemical purity. (Tan, et al., 2009; Zhou, et al., 2001) . Indones. J. Cancer Chemoprevent., 10(2), 80-87 out addition bifungctional agent. Three parameters which influence the labeling process have been varied to find the optimum labeling condition (Widyasari, et al., 2019) . In this study pH variations were not carried out like the previous study, because in this study using a phosphate buffer (pH 7.5) which would maintain the pH of the solution around 7. Rutin is a flavonoid antioxidant compound that is insoluble in water and the pH of the solution also greatly affects its solubility. At acidic pH the rutin solubility will decrease while at alkaline pH there will be degradation (Jurasekova, et al., 2014) . In addition, at neutral pH the chance of radiolysis will be very small.
Stability of 99m Tc-rutin in Room Temperature

RESULT AND DISCUSSION
The identification of 99m
Tc-rutin labeling efficiency was performed by ITLC-SG with mixture of ethanol, water, and ammonia (2:5:1) as the solvent to separate 99m TcO 2 impurities (Thrall, et al., 1978) . In this system, the colloid ( Tcrutin migrated to the top. This statement difference with Bernardo, et al., 2001 which state that "The colloid migrates to the top of the strip due to its apolar characteristics" (Bernardo, et al., 2001) . While to separated free 99m TcO 4 -impurities using system TLC-SG with salin as the solvent, free 99m TcO 4 -im- Tc complex with the ligand. The result of variation SnCl 2 .2H 2 O showed in Figure 3 and the highest radiochemical purity of 99m Tc-rutin was reached at 20 µg of SnCl 2 .2H 2 O with the labeling efficiency 96.44 ± 2.07 %. Figure 3 shows that the higher level of SnCl 2 then 20 µg make the radiochemical purity decreased, this is caused by the higher level of SnCl 2 make the higher level of 99m Tc-reduce impurities.
The second parameter was the amount of rutin as a ligand. Rutin is a yellow crystalline solid which is insoluble in water. In this study, rutin was dissolved in ethanol. The optimum rutin amount in the labeling process was shown in Figure 4 . Figure  4 shows that the optimal rutin amount was 700 µg with the labeling efficiency 95.83 ± 0.90 %. Figure  4 illustrates that radiochemical purity of 99m Tc-rutin was stable in rutin amount higher than 700 µg, this is caused by that almost all technetium-99m present in the system has bonded with rutin so the addition of rutin has no effect.
The third parameter was the optimum incubation time. The optimum incubation time is the reaction time that results in the highest labeling efficiency. In this study, incubation was done at room temperature to avoid degradation of rutin as antioxidant compounds. The optimum incubation time was shown in Figure 5 . From this figure with the three times repetitions data, we can see that the highest labeling efficiency was reached just after the addition of technetium-99m and the labeling efficiency was not much different for up to 60 minutes. of labeled compound aim to find out information about how long the labeled compound were still good in storage. The quality of labeled compound is determined by the radiochemical purity. The good radiopharmaceuticals are labeled compounds that have radiochemical purity greater than 90 % (Zolle, 2007) . The half-life of labeled compound is influenced by the radioisotope that labeled that compound. The stability analysis of 99m Tc-rutin in room temperature showed that until 4 hours storage the labeled compound still has high labeling efficiency ( Figure 6 ). In this study the stability determination of 99m Tc-rutin carried for up to 4 hours, because the half-life of Tc-99m is 6 hours and over 4 hours the radioactivity of 99m Tc-rutin decreased so the radioactivity dose that must be given in preclinical/clinical testing will be different. From the statistical analysis using ANOVA and continued with the Tukey analysis showing the results that the radiochemical purity of 99m Tc-rutin from 0 to 4 hours does not show significantly different results, it is shown that the labeled compounds 99m Tc-rutin is stable up to 4 hours. The information of stability is required when applied in nuclear medicine.
Rutin labeled with technetium already published by Bernardo (Bernardo, et al., 2001 ) but in the paper was not clearly informed the optimum formulation to produced 99m Tc-rutin with high radiochemical purity. From this study, the optimum formulation to produce 99m Tc-rutin with high radiochemical purity can be known. By obtaining 99m Tc-rutin with high radiochemical purity, it can be used as a radiotracer to study the effectiveness of rutin as an anticancer from natural compound.
CONCLUSION
This study described the method and formulation for preparation 99m Tc-rutin complex. Tcrutin was successfully prepared with direct labeling method with labeling efficiency was 99.28 ± 0.15 %. The optimum labeled condition obtained from this study was 20 µg SnCl 2 .2H 2 O as reductor, 700 µg rutin hydrate as a ligand and without incubation time at room temperature. The 99m Tc-rutin complex was stable in room temperature until 4 h after labeling. With this successfully to preparation 99m Tcrutin there is an opportunity to continue to in vitro and in vivo study.
